{"id":"CHEMBL1009","canonicalSmiles":"N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O","inchiKey":"WTDRDQBEARUVNC-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVODOPA","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bendopa","Brocadopa","Dopar","Inbrija","Larodopa"],"synonyms":["Bendopa","Levodopa","NSC-118381","V-1512"],"crossReferences":{"DailyMed":["levodopa"],"PubChem":["104171278","11111115","11112155","11532916","144203889","26753566","90341430"],"Wikipedia":["L-DOPA"],"drugbank":["DB01235"],"chEBI":["15765"]},"count":20,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000151577"],"count":1},"linkedDiseases":{"rows":["MONDO_0043209","EFO_0002610","EFO_0001365","MONDO_0002009","EFO_1000809","EFO_0005252","EFO_1001919","EFO_0003768","Orphanet_72","MONDO_0002050","EFO_0003860","EFO_0000712","EFO_0005424","EFO_0003839","EFO_0000253","MONDO_0001162","EFO_0000692","EFO_0003756","EFO_0002508","MONDO_0001020","EFO_0001358","HP_0002381","HP_0003418","Orphanet_55","EFO_0003843","Orphanet_791","EFO_0008623","EFO_0004895","EFO_0000270","MONDO_0043510","EFO_0004270"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for parkinson's disease and has 19 investigational indications."}
{"id":"CHEMBL101","canonicalSmiles":"CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O","inchiKey":"VYMDGNCVAMGZFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLBUTAZONE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Hematological toxicity"," Misuse"],"year":1985},"tradeNames":["Antadol","Azolid","Butacote","Butaject","Butazolidin","Elmedal","Equiphar","Phenylbutazone","Pro-Bute"],"synonyms":["Diphenylbutazone","Phenylbutazone"],"crossReferences":{"PubChem":["104171220","104171221","11111674","144203793","144203794","144209007","144213080","170465040","17389760","26747057","26751573","50104199","56436656","85231197","855958","90341773"],"TG-GATEs":["11"],"Wikipedia":["Phenylbutazone"],"drugbank":["DB00812"],"chEBI":["48574"]},"childChemblIds":["CHEMBL3137687"],"count":3,"approvedIndications":["HP_0002829","HP_0003326","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_0005755"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 3 approved indications. It was withdrawn in Germany  in 1985 due to Hematological toxicity and  Misuse."}
{"id":"CHEMBL101541","canonicalSmiles":"Nc1nc2ncc(CO)nc2c(=O)[nH]1","inchiKey":"XGWIBNWDLMIPNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL101541","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1027","canonicalSmiles":"Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C","inchiKey":"PBJUNZJWGZTSKL-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIAGABINE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gabitril"],"synonyms":["A-70569-1","ABBOTT-70569","ABBOTT-70569 FREE BASE","ABBOTT-70569-1","ABBOTT-705691 FREE BASE","ABT-569","ABT-569 FREE BASE","Gabitril","NNC-05-0328","NNC-050328 FREE BASE","NO-05-0328","NO-050328 FREE BASE","Tiagabine"],"crossReferences":{"DailyMed":["tiagabine%20hydrochloride"],"PubChem":["26758048"],"Wikipedia":["Tiagabine"],"drugbank":["DB00906"],"chEBI":["9586"]},"childChemblIds":["CHEMBL1695"],"count":6,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000157103"],"count":1},"linkedDiseases":{"rows":["EFO_1001892","EFO_0000474","EFO_0002610","EFO_1001917","EFO_0005230","EFO_0000692","EFO_0003918","EFO_0003829"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for epilepsy and has 5 investigational indications."}
{"id":"CHEMBL1054","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O","inchiKey":"LMJSLTNSBFUCMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHLORMETHIAZIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metahydrin","Naqua","Trichlorex","Trichlormas","Trichlormethiazide"],"synonyms":["Trichlormethiazide"],"crossReferences":{"PubChem":["144203972","170464812","56422224","855703"],"Wikipedia":["Trichlormethiazide"],"drugbank":["DB01021"],"chEBI":["9683"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1075","canonicalSmiles":"CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2","inchiKey":"FUBVWMNBEHXPSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MORICIZINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ethmozine"],"synonyms":["EN-313","EN-313 FREE BASE","Ethmozine","Moracizine","Moricizine"],"crossReferences":{"PubChem":["11112721","174006664","50086819"],"Wikipedia":["Moracizine"],"drugbank":["DB00680"],"chEBI":["6997"]},"childChemblIds":["CHEMBL1200334"],"count":2,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for cardiac arrhythmia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1082407","canonicalSmiles":"CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F","inchiKey":"WXCXUHSOUPDCQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENZALUTAMIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xtandi"],"synonyms":["Enzalutamide","MDV-3100","MDV3100"],"crossReferences":{"DailyMed":["enzalutamide"],"PubChem":["137275964"],"drugbank":["DB08899"],"chEBI":["68534"]},"childChemblIds":["CHEMBL4594421"],"count":18,"approvedIndications":["EFO_0000616","EFO_0000673","EFO_0000196","EFO_0001663","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0003086","EFO_0003859","MONDO_0015686","MONDO_0008170","EFO_0000349","MONDO_0007254","EFO_0000313","EFO_1001469","MONDO_0044915","EFO_0000305","MONDO_0008315","EFO_0001663","MONDO_0001187","EFO_0000311","EFO_1000499","EFO_0000182","EFO_0000673","EFO_0000196","EFO_0001421"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 5 approved and 13 investigational indications."}
{"id":"CHEMBL1089","canonicalSmiles":"NNCCc1ccccc1","inchiKey":"RMUCZJUITONUFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PHENELZINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nardil","Phenelzine"],"crossReferences":{"DailyMed":["phenelzine%20sulfate"],"PubChem":["11111653","11111654","174006798","50111200","90341694"],"Wikipedia":["Phenelzine"],"drugbank":["DB00780"],"chEBI":["8060"]},"childChemblIds":["CHEMBL1200895"],"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["EFO_0000673","MONDO_0007254","EFO_0003761"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL109822","canonicalSmiles":"CCCCn1c(Cc2ccc3c(c2)OCO3)nc2c(N)nc(F)nc21","inchiKey":"ARWHTQLGMWHTAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109822","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL11306","canonicalSmiles":"CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](CC(=O)NO)CC(C)C","inchiKey":"MOPRTFSMCQNUCT-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL11306","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08403"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1138","canonicalSmiles":"O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1","inchiKey":"OLNTVTPDXPETLC-XPWALMASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZETIMIBE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ezetimibe","Ezetrol","Zetia"],"synonyms":["Ezetimibe","MK0653","SCH-58235","SCH58235"],"crossReferences":{"DailyMed":["ezetimibe"],"PubChem":["144204996","170465013","26719841"],"Wikipedia":["Ezetimibe"],"drugbank":["DB00973"],"chEBI":["49040"]},"count":18,"approvedIndications":["HP_0003124","EFO_0003774","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000015520"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003095","Orphanet_68367","EFO_0003762","EFO_0003774","EFO_0000266","EFO_1001461","EFO_0007304","EFO_0003914","EFO_0004211","Orphanet_391665","EFO_0003047","EFO_0000400","HP_0003124","HP_0001919","EFO_0001645","EFO_0000319","EFO_0004911","MONDO_0008315","Orphanet_309005","EFO_0000537","EFO_0000195","EFO_0000589","EFO_0004220","EFO_0000764","EFO_0000612","EFO_0001360","EFO_0005672","EFO_0004265"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 3 approved and 15 investigational indications."}
{"id":"CHEMBL1160593","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1Br","inchiKey":"LHLHVDBXXZVYJT-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160593","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01903"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161632","canonicalSmiles":"O=C(O)O","inchiKey":"BVKZGUZCCUSVTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BICARBONATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bicarbonate","Bicarbonate Ion","Carbonic Acid Anion","Hydrogen Carbonate"],"crossReferences":{"Wikipedia":["Carbonic_acid"],"chEBI":["28976"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1163065","canonicalSmiles":"C[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"CWWYMWDIYBJVLP-YTMOPEAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALASA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AlaSA"],"crossReferences":{"drugbank":["DB03376"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1163086","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NC(=O)[C@@H]2CCCN2)[C@@H](O)[C@H]1O","inchiKey":"LKVJEMXWEODCAY-JVEUSOJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1163086","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02510"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1171829","canonicalSmiles":"C[C@H](Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2F)CC1)C(F)(F)F","inchiKey":"YUUGYIUSCYNSQR-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BITOPERTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bitopertin","R-1678","RG-1678","RO-4917838","RO-4917939","RO4917838"],"crossReferences":{"drugbank":["DB12426"]},"count":3,"linkedTargets":{"rows":["ENSG00000196517"],"count":1},"linkedDiseases":{"rows":["Orphanet_848","EFO_0004242","EFO_0000692"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1189679","canonicalSmiles":"O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2","inchiKey":"CPZBLNMUGSZIPR-NVXWUHKLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALONOSETRON","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aurothioglucose","Palonosetron"],"crossReferences":{"DailyMed":["palonosetron%20hydrochloride"],"Wikipedia":["Palonosetron"],"drugbank":["DB00377"],"chEBI":["85161"]},"childChemblIds":["CHEMBL1720"],"count":14,"approvedIndications":["EFO_0006911","HP_0002018"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","HP_0000486","EFO_0006911","EFO_0000756","EFO_0003843","EFO_0000311","HP_0002018","EFO_0000565","MONDO_0015917","MONDO_0001056","HP_0002017","MONDO_0001657","EFO_0004888","EFO_0000574","HP_0002013","EFO_0001378"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for nausea and chemotherapy-induced nausea and vomiting and has 12 investigational indications."}
{"id":"CHEMBL1200347","canonicalSmiles":"CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C.[I-]","inchiKey":"BFSMWENDZZIWPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROPAMIDE IODIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201232","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Darbid"],"synonyms":["Isopropamide iodide","Isoproponum iodide"],"crossReferences":{"PubChem":["11532965","56424103"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957."}
{"id":"CHEMBL1200595","canonicalSmiles":"CC(C)(N)Cc1ccc(Cl)cc1.Cl","inchiKey":"WEJDYJKJPUPMLH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENTERMINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201269","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Cardiotoxicity"],"year":1969},"tradeNames":["Pre-sate"],"synonyms":["Chlorphentermine hydrochloride","S-62","W 2426","W-2426"],"crossReferences":{"PubChem":["144205357","170465307"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982. It was withdrawn in Germany  in 1969 due to Cardiotoxicity."}
{"id":"CHEMBL1200750","canonicalSmiles":"CC(CN1c2ccccc2Sc2ccccc21)N(C)C.Cl","inchiKey":"XXPDBLUZJRXNNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROMETHAZINE HYDROCHLORIDE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL643","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mymethazine fortis","Phenergan","Phenergan nightime","Phenhalal","Phensedyl","Prometh fortis","Prometh plain","Promethacon","Promethazine","Promethazine hydrochloride","Promethazine hydrochloride plain","Promethazine plain","Promethegan","Q-mazine","Remsed","Sarantihist","Sominex","Zipan-25","Zipan-50"],"synonyms":["Promethazine hydrochloride"],"crossReferences":{"DailyMed":["promethazine%20hydrochloride"],"PubChem":["144209462","144213195","26747605","26747606","26752305","50106751","50106752","50106753","56422196","567521","855711"],"chEBI":["8462"]},"count":6,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005296","EFO_0005295","EFO_0004698","EFO_1000971","EFO_0003843","EFO_0003785"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and is indicated for pain and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200752","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O.O=S(=O)(O)O","inchiKey":"PVGPXGKNDGTPTD-ODJCEOKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1200752","maximumClinicalTrialPhase":0,"parentId":"CHEMBL517712","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200821","canonicalSmiles":"CCCOC(=O)Cn1cc(I)c(=O)c(I)c1","inchiKey":"ROSXARVHJNYYDO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPYLIODONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dionosil","Dionosil aqueous","Dionosil oily"],"synonyms":["Propyliodone"],"crossReferences":{"Wikipedia":["Propyliodone"],"drugbank":["DB09366"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200928","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].[Zn+2]","inchiKey":"DJWUNCQRNNEAKC-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Galzin"],"synonyms":["E650","NPC-02","NSC-75801","Npc-02","Zinc acetate","Zinc acetate dihydrate","Zinc acetate hydrate"],"crossReferences":{"DailyMed":["zinc%20acetate"],"DrugCentral":["4269"],"PubChem":["144212333"],"Wikipedia":["Zinc_acetate"],"drugbank":["DB14487"],"chEBI":["62984"]},"childChemblIds":["CHEMBL3184986"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1200934","canonicalSmiles":"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC","inchiKey":"KIQQMECNKUGGKA-NMYWJIRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORGESTIMATE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dexnorgestrel acetime","Norgestimate","ORF 10131","ORF-10131","RWJ 10131","RWJ-10131"],"crossReferences":{"DailyMed":["norgestimate"],"PubChem":["144206364","170464733","50125945"],"Wikipedia":["Norgestimate"],"drugbank":["DB00957"],"chEBI":["50815"]},"count":8,"approvedIndications":["EFO_0003894"],"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0004220","EFO_0003821","EFO_0000764","Orphanet_586","EFO_0003047","HP_0100608","EFO_0003894","EFO_0003882","Orphanet_3388"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for acne and has 7 investigational indications."}
{"id":"CHEMBL1201046","canonicalSmiles":"NCc1ccccc1CC(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3CC(=O)O)CS[C@H]12","inchiKey":"SLAYUXIURFNXPG-CRAIPNDOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFORANIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Precef"],"synonyms":["BL-S786","Ceforanide"],"crossReferences":{"PubChem":["144204221"],"Wikipedia":["Ceforanide"],"drugbank":["DB00923"],"chEBI":["3495"]},"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for bacterial disease."}
{"id":"CHEMBL1201287","canonicalSmiles":"CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1","inchiKey":"ZDIGNSYAACHWNL-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXBROMPHENIRAMINE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dexbrompheniramine"],"crossReferences":{"PubChem":["29216402","90341837"],"Wikipedia":["Dexbrompheniramine"],"drugbank":["DB00405"],"chEBI":["59269"]},"childChemblIds":["CHEMBL1200638"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1963 and is indicated for allergy."}
{"id":"CHEMBL1201548","drugType":"Unknown","blackBoxWarning":false,"name":"TYLOXAPOL","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alevaire","Superinone"],"synonyms":["Tyloxapol"],"crossReferences":{"DrugCentral":["4738"],"Wikipedia":["Tyloxapol"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1201794","canonicalSmiles":"Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C","inchiKey":"FVTCRASFADXXNN-SCRDCRAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOFLAVIN 5'-PHOSPHATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E101a","Flavin mononucleotide","Riboflavin 5'-phosphate","Riboflavin phosphate"],"crossReferences":{"DailyMed":["riboflavin%205'-phosphate%20sodium"],"Wikipedia":["Flavin_mononucleotide"],"drugbank":["DB03247"],"chEBI":["17621"]},"childChemblIds":["CHEMBL3989697"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1205452","canonicalSmiles":"O=C(O)c1ccc2cc(C(=O)O)ccc2c1","inchiKey":"RXOHFPCZGPKIRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1205452","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208320"],"drugbank":["DB08262"],"chEBI":["44460"]},"childChemblIds":["CHEMBL99236"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1208","canonicalSmiles":"CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3","inchiKey":"VDUWPHTZYNWKRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINOXACIN","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cinobac","Cinoxacin"],"synonyms":["64716","Cinoxacin","NSC-304467"],"crossReferences":{"PubChem":["11110995","11110996","144203672","170465414","50104192","50104193","56422419","85230984","855948","90341598"],"Wikipedia":["Cinoxacin"],"drugbank":["DB00827"],"chEBI":["3716"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1208309","canonicalSmiles":"CCCCCCCCCCCCCCCCS(=O)(=O)O","inchiKey":"SSILHZFTFWOUJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1208309","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02776"],"chEBI":["43043"]},"childChemblIds":["CHEMBL549811"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213633","canonicalSmiles":"CON","inchiKey":"GMPKIPWJBDOURN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOXYAMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methoxyamine"],"crossReferences":{"drugbank":["DB06328"]},"childChemblIds":["CHEMBL1609430"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1215331","canonicalSmiles":"N#Cc1ccc(N2N=C3c4ccc(C(=O)O)cc4CC[C@@H]3[C@@H]2C2CCCC2)cc1Cl","inchiKey":"XNULRSOGWPFPBL-REWPJTCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-3882845","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-3882845"],"crossReferences":{"drugbank":["DB11814"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1221","canonicalSmiles":"Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1","inchiKey":"AFNXATANNDIXLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULCONAZOLE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Exelderm","Sulconazole"],"crossReferences":{"DailyMed":["sulconazole%20nitrate"],"Wikipedia":["Sulconazole"],"drugbank":["DB06820"],"chEBI":["77776"]},"childChemblIds":["CHEMBL1200348"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1222152","canonicalSmiles":"OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O","inchiKey":"WQZGKKKJIJFFOK-IVMDWMLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-ALLOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Allose"],"crossReferences":{"drugbank":["DB03989"],"chEBI":["4093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230227","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3C[C@](O)(C(=O)CO)Cc4c(O)c5c(c(O)c43)C(=O)c3ccccc3C5=O)O[C@H]2C)C[C@H](N)[C@@H]1O","inchiKey":"VQHRZZISQVWPLK-UIRGBLDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SABARUBICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sabarubicin"],"crossReferences":{"drugbank":["DB12410"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1231821","canonicalSmiles":"Cl","inchiKey":"VEXZGXHMUGYJMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCHLORIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E507","Hydrochloric acid"],"crossReferences":{"Wikipedia":["Hydrochloric_acid","Hydrogen_chloride"],"drugbank":["DB13366"],"chEBI":["17883"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232472","canonicalSmiles":"COC(=O)[C@H]1[C@@H](O)C[C@@H]2CC[C@H]1N2C","inchiKey":"QIQNNBXHAYSQRY-UYXSQOIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232472","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04688"],"chEBI":["31529"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232501","canonicalSmiles":"N[C@@H](Cc1cccc(O)c1)C(=O)O","inchiKey":"JZKXXXDKRQWDET-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232501","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03552"],"chEBI":["44303"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234848","canonicalSmiles":"O=C(O)CN(CC(=O)O)CC(=O)O","inchiKey":"MGFYIUFZLHCRTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITRILOTRIACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209393","144210476","17389804","26752915","8139938"],"drugbank":["DB03040"],"chEBI":["44557"]},"childChemblIds":["CHEMBL1905907"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237055","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5.Cl","inchiKey":"XHILEZUETWRSHC-NRGUFEMZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HYDROMORPHONE HYDROCHLORIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL398707","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dilaudid","Dilaudid-hp","Exalgo","Hydromorphone hydrochloride","Palladone","Palladone-sr"],"synonyms":["Dihydromorphinone hydrochloride","Hydromorphone HCl","Hydromorphone hydrochloride","Hydromorphone hydrochloride cii","NSC-117862"],"crossReferences":{"DailyMed":["hydromorphone%20hydrochloride"],"chEBI":["5791"]},"count":7,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","HP_0012532","Orphanet_232","EFO_1000786","EFO_0001421","EFO_0004616","HP_0003419","HP_0003418","EFO_0003843"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for pain and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL125181","canonicalSmiles":"CN[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NC[C@H]1CC[C@H](N)CC1","inchiKey":"MDSVGJAUFNXYRR-WTGUMLROSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-371912","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-371912"],"crossReferences":{"drugbank":["DB08187"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256716","canonicalSmiles":"COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1.Cl","inchiKey":"KTMLZVUAXJERAT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URAPIDIL HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL279229","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Urapidil hydrochloride"],"crossReferences":{"PubChem":["144204838","170466013","26719667","50107216"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1256786","canonicalSmiles":"COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1","inchiKey":"BPZSYCZIITTYBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMOTEROL","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Foradil","Formoterol"],"crossReferences":{"DailyMed":["formoterol%20fumarate","formoterol%20fumarate%20dihydrate"],"PubChem":["50125837"],"drugbank":["DB00983"],"chEBI":["63082"]},"childChemblIds":["CHEMBL2133469","CHEMBL1893395","CHEMBL3989798"],"count":4,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0007183","EFO_0000464","EFO_0000249","EFO_0009661","EFO_0003768","EFO_1000637","HP_0002110","HP_0006536","MONDO_0100096","EFO_0000270","MONDO_0008903","EFO_0006505","EFO_0000341","HP_0025428","EFO_0003785"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for airway obstruction and has 3 investigational indications."}
{"id":"CHEMBL1257015","canonicalSmiles":"COc1ccc(C(=O)NCc2cccnc2)cc1C(=O)NCc1cccnc1","inchiKey":"KYWCWBXGRWWINE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICOTAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Picotamide"],"crossReferences":{"PubChem":["11111675","50106897","85231198","90341089"],"drugbank":["DB13327"]},"childChemblIds":["CHEMBL1317747"],"count":1,"approvedIndications":["HP_0004419"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for recurrent thrombophlebitis."}
{"id":"CHEMBL1259","canonicalSmiles":"COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3","inchiKey":"JFXBEKISTKFVAB-AJQTZOPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOCURINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dimethyltubocurarine","Metocurine"],"crossReferences":{"Wikipedia":["Metocurine"],"drugbank":["DB01336"],"chEBI":["6900"]},"childChemblIds":["CHEMBL1739","CHEMBL2105841"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL127907","canonicalSmiles":"COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC","inchiKey":"BNDYIYYKEIXHNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WHI-P180","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WHI-P180"],"crossReferences":{"drugbank":["DB03365"]},"childChemblIds":["CHEMBL1641775"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1280","canonicalSmiles":"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl","inchiKey":"DOQPXTMNIUCOSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERAPAMIL HYDROCHLORIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL6966","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Berkatens","Calan","Calan sr","Cordilox","Cordilox i.v.","Cordilox mr 240","Covera","Covera-hs","Ethimil mr 240","Geangin","Half securon sr","Isoptin","Isoptin Sr","Manidon sr","Ranvera mr","Securon","Securon iv","Securon mid","Securon sr","Univer","Vera-til sr","Verapamil hydrochloride","Verapress mr 240","Verelan","Verelan pm","Vertab sr 240","Zolvera"],"synonyms":["CP-16533-1","LU-20175","NSC-272366","NSC-657799","Verapamil hydrochloride"],"crossReferences":{"DailyMed":["verapamil%20hydrochloride"],"PubChem":["144208378","17388668","26747697","26747698","49718106","50107178","50107179","50107180","507863","856000"]},"count":5,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003144","EFO_0000319","EFO_0000183","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for hypertension and has 4 investigational indications."}
{"id":"CHEMBL129482","canonicalSmiles":"Oc1cc(O)c2c(c1)O[C@@H](c1ccc(O)c(O)c1)[C@@H](O)C2","inchiKey":"PFTAWBLQPZVEMU-ZFWWWQNUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-EPICATECHIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+)-epicatechin","Epicatechin"],"crossReferences":{"chEBI":["76125"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL134529","canonicalSmiles":"COC(=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"IZZJOGWXTFEDLL-XUUWZHRGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL134529","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03657"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL134561","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)OC(C1CC1)C=C2","inchiKey":"HWJPWWYTGBZDEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICLAPRIM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-100","Iclaprim","RO 48-2622","RO-48-2622","Ro-482622"],"crossReferences":{"Wikipedia":["Iclaprim"],"drugbank":["DB06358"]},"childChemblIds":["CHEMBL2105645"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1370446","canonicalSmiles":"Cc1sc2ccccc2c1CC1=NCCN1","inchiKey":"NDNKHWUXXOFHTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METIZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metizoline"],"crossReferences":{"PubChem":["11110847","90341028"],"drugbank":["DB13614"]},"childChemblIds":["CHEMBL2106879","CHEMBL1605189"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL14130","canonicalSmiles":"O=[N+]([O-])c1ccc(O)cc1","inchiKey":"BTJIUGUIPKRLHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"P-NITROPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR-1C2"],"crossReferences":{"PubChem":["144209642","144210437"],"Wikipedia":["4-Nitrophenol"],"drugbank":["DB04417"],"chEBI":["16836"]},"childChemblIds":["CHEMBL3183771"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1441","canonicalSmiles":"CCc1cc(C(N)=S)ccn1","inchiKey":"AEOCXXJPGCBFJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHIONAMIDE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trecator","Trecator-sc"],"synonyms":["1314 TH","1314-TH","BAYER 5312","Ethionamide","NSC-255115"],"crossReferences":{"DailyMed":["ethionamide"],"PubChem":["104171307","11112402","11532957","144209607","144213086","170465169","17389895","26752898","56422118","85148756"],"TG-GATEs":["135"],"Wikipedia":["Ethionamide"],"drugbank":["DB00609"],"chEBI":["4885"]},"count":3,"approvedIndications":["Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for tuberculosis and has 2 investigational indications."}
{"id":"CHEMBL1484251","canonicalSmiles":"Cl.Cl.N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1","inchiKey":"WJLVQTJZDCGNJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORHEXIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL790","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorhex hcl"],"synonyms":["AY-5312","Chlorhexidine hydrochloride"],"crossReferences":{"PubChem":["144213006","26747927"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1511","canonicalSmiles":"CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C","inchiKey":"RSEPBGGWRJCQGY-RBRWEJTLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRADIOL VALERATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Climaval","Delestrogen","Estradiol valerate","Femtab","Progynon depot","Progynon-depot-10","Progynova"],"synonyms":["Estradiol 17-valerate","Estradiol Valerate","Estradiol valerate","NSC-17590","Oestradiol valerate"],"crossReferences":{"DailyMed":["estradiol%20valerate"],"PubChem":["144204865","56422428","855707"],"drugbank":["DB13956"],"chEBI":["31561"]},"count":8,"approvedIndications":["MONDO_0002146","HP_0008209","HP_0000132"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_1001271","EFO_0004248","MONDO_0002146","Orphanet_64739","EFO_0000545","HP_0008209","HP_0100607","HP_0000132","HP_0100608","MONDO_0002775","EFO_0003882","EFO_0000660","EFO_0003922"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL15870","canonicalSmiles":"CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1","inchiKey":"RJMIEHBSYVWVIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOPROFEN","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Spain"," Germany"],"classes":["Carcinogenicity"," Gastrotoxicity"],"year":1983},"tradeNames":[],"synonyms":["Indoprofen","K 4277"],"crossReferences":{"PubChem":["11532964","144204869","26748086"],"Wikipedia":["Indoprofen"],"drugbank":["DB08951"],"chEBI":["76162"]},"count":1,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for rheumatic disease. It was withdrawn in United Kingdom,  Spain and  Germany initially in 1983 due to Carcinogenicity and  Gastrotoxicity."}
{"id":"CHEMBL1716091","canonicalSmiles":"CCc1cccc2c3c([nH]c12)[C@@](CC)(CC(=O)O)OCC3","inchiKey":"NNYBQONXHNTVIJ-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SDX-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KS-1056","RAK-593","SDX-101","Sdx-101"],"crossReferences":{"PubChem":["11112763"],"chEBI":["60370"]},"count":2,"linkedTargets":{"rows":["ENSG00000186350"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0001378"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743014","drugType":"Antibody","blackBoxWarning":false,"name":"ETARACIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Abegrin","Abegrin vitaxin"],"synonyms":["ETARATUZUMAB","Etaracizumab","HLM60","MEDI-522"],"count":8,"linkedTargets":{"rows":["ENSG00000259207","ENSG00000138448"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000756","EFO_0000681","EFO_0000676","MONDO_0008315","EFO_0002617","EFO_1001951","EFO_0000311"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1743066","drugType":"Antibody","blackBoxWarning":false,"name":"RONTALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7415","RHUMAB IFNALPHA","RHUMAB-IFNALPHA","Rontalizumab"],"count":1,"linkedTargets":{"rows":["ENSG00000228083","ENSG00000233816","ENSG00000197919","ENSG00000137080","ENSG00000214042","ENSG00000120242","ENSG00000234829","ENSG00000186803","ENSG00000236637","ENSG00000120235","ENSG00000188379","ENSG00000147873","ENSG00000147885"],"count":13},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1788401","canonicalSmiles":"COC(=O)Nc1nc2ccc(C(=O)C3CC3)cc2[nH]1","inchiKey":"OXLKOMYHDYVIDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBENDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ciclobendazole","Cyclobendazole","R 17,147"],"crossReferences":{"PubChem":["121283140","170466492"],"drugbank":["DB13465"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1852492","canonicalSmiles":"COc1cc(C(=O)c2c(C)oc3c(OP(=O)(O)O)c(OC)ccc23)cc(OC)c1OC","inchiKey":"MYDHDVLPMRNDAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1852492","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06313"]},"childChemblIds":["CHEMBL1823160"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1893395","canonicalSmiles":"COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"ZDUPYZMAPCZGJO-WLHGVMLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1893395","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1256786","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["147911","99360977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908336","canonicalSmiles":"CCOC(=O)[C@@H]1CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@H]1OC","inchiKey":"NGNBWGMTPDSDCJ-QDFUUMMMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIDECAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Midecamycin","Midecamycin acetate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL195328","canonicalSmiles":"Nc1ccccc1F","inchiKey":"FTZQXOJYPFINKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Fluoro-Phenylamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Fluoro-Phenylamine","2-Fluorobenzenaminium"],"crossReferences":{"drugbank":["DB02403"],"chEBI":["27526"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL195560","canonicalSmiles":"Oc1ccc(C2=COc3cc(O)ccc3C2)cc1","inchiKey":"QCNUDDPWPNUALZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPHENOXODIOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isophenoxodiol"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2030402","canonicalSmiles":"O=c1[nH]c([C@@H]2CCCN2)nc2c1oc1ccc(Cl)cc12","inchiKey":"JJWLXRKVUJDJKG-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2030402","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12357"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2040682","canonicalSmiles":"CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C","inchiKey":"LUKZNWIVRBCLON-GXOBDPJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CICLESONIDE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alvesco","Alvesco 160","Alvesco 80","Omnaris","Zetonna"],"synonyms":["BI54903","Ciclesonide","RPR-251526","RPR251526"],"crossReferences":{"DailyMed":["ciclesonide"],"PubChem":["144206039"],"drugbank":["DB01410"]},"count":7,"approvedIndications":["EFO_0005854","HP_0006536","EFO_0000270","HP_0001742","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0006536","MONDO_0100096","EFO_0000270","EFO_1000024","EFO_0000341","EFO_1001417","HP_0001742","EFO_0003956","EFO_0003785"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 5 approved and 2 investigational indications."}
{"id":"CHEMBL2096642","canonicalSmiles":"CC(O)C(=O)O.Nc1cc(-c2ccncc2)c[nH]c1=O","inchiKey":"DOSIONJFGDSKCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INAMRINONE LACTATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL12856","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amrinone lactate","Inocor"],"synonyms":["Inamrinone lactate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984."}
{"id":"CHEMBL2103773","canonicalSmiles":"CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1.[Br-]","inchiKey":"VWZPIJGXYWHBOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTILONIUM BROMIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1433361","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Otilonium bromide","SP-63","SP63"],"crossReferences":{"PubChem":["144205612","170466098"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2103832","canonicalSmiles":"CN1CCN(c2cccc3[nH]c(=O)oc23)CC1","inchiKey":"YVPUUUDAZYFFQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARDOPRUNOX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DU 126891","DU-126891","Pardoprunox","SLV 308","SLV-308","SLV308"],"crossReferences":{"drugbank":["DB12061"]},"childChemblIds":["CHEMBL2105649"],"count":1,"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2103842","canonicalSmiles":"C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1","inchiKey":"UWXSAYUXVSFDBQ-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARLITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-00334543","ARRY-334543","ARRY-543","ASLAN-001","ASLAN001","Varlitinib"],"crossReferences":{"drugbank":["DB05944"]},"childChemblIds":["CHEMBL2105679"],"count":8,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0001056","MONDO_0003060","EFO_0000616","EFO_0000182","MONDO_0007254","EFO_0005221","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2104149","canonicalSmiles":"CCC(=O)n1c(=O)n(C2CCN(CCC(C#N)(c3ccccc3)c3ccccc3)CC2)c2ccccc21","inchiKey":"FLKWNFFCSSJANB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEZITRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bezitramide","R 4845"],"crossReferences":{"drugbank":["DB01459"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104283","canonicalSmiles":"CCCCOCC(CN1C(=O)NC(=O)C(CC)(c2ccccc2)C1=O)OC(N)=O","inchiKey":"QHZQILHUJDRDAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEBARBAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Febarbamate","GO-560","Phenobamate"],"crossReferences":{"drugbank":["DB13303"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104489","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CCC2[C@@H]3C[C@H](C)C4=CCCC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"KDLNOQQQEBKBQM-HDFGVWRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAGESTONE ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Carcinogenicity"],"year":1969},"tradeNames":["Anatropin"],"synonyms":["Anagestone","Anagestone acetate"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1969 due to Carcinogenicity."}
{"id":"CHEMBL2104496","canonicalSmiles":"Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1.O=[N+]([O-])[O-]","inchiKey":"UIERGBJEBXXIGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMINE MONONITRATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1547","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thiamine mononitrate","Thiamine nitrate","Vitamin b1 mononitrate"],"crossReferences":{"PubChem":["144212638"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105116","canonicalSmiles":"Nc1nc(=O)c2sc(=O)n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1","inchiKey":"TZYVRXZQAWPIAB-FCLHUMLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISATORIBINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04860"]},"childChemblIds":["CHEMBL3989482"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105133","canonicalSmiles":"CCCc1c2oc(C(=O)[O-])cc(=O)c2cc2c(=O)cc(C(=O)[O-])n(CC)c12.[Ca+2]","inchiKey":"FGUNXXYEYHFDNX-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"NEDOCROMIL CALCIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL746","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FPL 59002KC","Nedocromil calcium"],"crossReferences":{"chEBI":["51030"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105401","canonicalSmiles":"O=c1oc2ccccc2c(O)c1C(CC(O)c1ccc(Cl)cc1)c1ccc(Cl)s1","inchiKey":"WRGOVNKNTPWHLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOCLOMAROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tioclomarol"],"crossReferences":{"drugbank":["DB13451"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105643","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO","inchiKey":"FIDMEHCRMLKKPZ-YSMBQZINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSBRETABULIN TROMETHAMINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1206232","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zybrestat"],"synonyms":["Fosbretabulin tromethamine"],"count":2,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000167552","ENSG00000137267","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_1001901","MONDO_0008170"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105897","canonicalSmiles":"O=S(=O)([O-])[O-].[Ba+2]","inchiKey":"TZCXTZWJZNENPQ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BARIUM SULFATE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bar-test","Baricon","Barocat","Barosperse","Barosperse ii","Barotrast","E-z-cat dry","E-z-hd","E-z-paque","Entero vu 24%","Epi-c","Epi-stat 57","Epi-stat 61","Esophotrast","Liquid e-z-paque","Oratrast","Readi-cat 2","Readi-cat 2 smoothie","Readi-cat 2 smoothies","Tagitol v","Varibar","Varibar honey","Varibar nectar","Varibar pudding","Varibar thin honey","Varibar thin liquid"],"synonyms":["Barium sulfate"],"crossReferences":{"DailyMed":["barium%20sulfate"],"DrugCentral":["4346"],"drugbank":["DB11150"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2016."}
{"id":"CHEMBL2107319","canonicalSmiles":"Cl.N[C@@H](CCC(=O)N[C@@H](CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)C(=O)N[C@@H](C(=O)O)c1ccccc1)C(=O)O","inchiKey":"NECZZOFFLFZNHL-XVGZVFJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANFOSFAMIDE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111086","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Telcyta"],"synonyms":["Canfosfamide hydrochloride","Canfosfamidhydrochloride","TER-286","TER286","TLK-286","TLK286"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2107366","canonicalSmiles":"Cc1cccc([C@H](C)c2c[nH]c(=S)[nH]2)c1C","inchiKey":"WQXVKEDUCPMRRI-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REZATOMIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-203818","Agn 203818","Rezatomidine"],"crossReferences":{"drugbank":["DB12143"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107890","drugType":"Antibody","blackBoxWarning":false,"name":"TAPLITUMOMAB PAPTOX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taplitumomab paptox"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108031","drugType":"Cell","blackBoxWarning":false,"name":"GALGENPROSTUCEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gvax prostate"],"synonyms":["CG1940","Galgenprostucel-l"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108265","drugType":"Small molecule","blackBoxWarning":false,"name":"CASCARA SAGRADA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Casc liq"],"synonyms":["Cascara","Cascara sagrada","Cascara sagrada fluidextract","Rhamnus purshiana"],"count":1,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for constipation."}
{"id":"CHEMBL2109225","drugType":"Unknown","blackBoxWarning":false,"name":"RUBELLA VIRUS VACCINE LIVE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Meruvax"],"synonyms":["Rubella virus vaccine live"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109253","drugType":"Antibody","blackBoxWarning":false,"name":"HOKT3","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HOKT3","Hokt3"],"count":2,"linkedTargets":{"rows":["ENSG00000198851"],"count":1},"linkedDiseases":{"rows":["EFO_0001359","EFO_0003778"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109304","drugType":"Antibody","blackBoxWarning":false,"name":"MDX-1303","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MDX-1303","Mdx-1303"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109416","drugType":"Antibody","blackBoxWarning":false,"name":"MORAB-028","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MORAB-028","Morab-028"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109460","drugType":"Antibody","blackBoxWarning":false,"name":"SCH-708980","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH-708980","Sch-708980"],"count":1,"linkedTargets":{"rows":["ENSG00000136634"],"count":1},"linkedDiseases":{"rows":["EFO_0005044"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109470","drugType":"Antibody","blackBoxWarning":false,"name":"PERAKIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perakizumab","RG-4934","RG4934","RO-5310074","RO5310074"],"count":1,"linkedTargets":{"rows":["ENSG00000112115"],"count":1},"linkedDiseases":{"rows":["EFO_0003778"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109572","drugType":"Antibody","blackBoxWarning":false,"name":"ANTI-SCLEROSTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-SCLEROSTIN"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109641","drugType":"Antibody","blackBoxWarning":false,"name":"4G7XH22","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4G7XH22","4g7xh22"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109679","drugType":"Antibody","blackBoxWarning":false,"name":"IDEC-159 111IN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDEC-159","Idec-159 (111in)","Idec-159 111in"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110784","canonicalSmiles":"CCOC(=O)CN1CCN(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)CC1","inchiKey":"XDUOTWNXVDBCDY-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINEPAZET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinepazet"],"crossReferences":{"drugbank":["DB13342"]},"childChemblIds":["CHEMBL2106028"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2133806","canonicalSmiles":"Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1","inchiKey":"JRWCBEOAFGHNNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-38877605","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-38877605","Jnj-38877605"],"crossReferences":{"PubChem":["137276033"],"drugbank":["DB13113"]},"count":1,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2138684","canonicalSmiles":"CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1.O.O=C(O)CCC(=O)O","inchiKey":"CUETXFMONOSVJA-KLQYNRQASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FROVATRIPTAN SUCCINATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1279","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Frova","Frovatriptan succinate"],"synonyms":["Frovatriptan succinate","SB 209509-AX","VML 251"],"crossReferences":{"DailyMed":["frovatriptan%20succinate"],"PubChem":["124894597","144207155"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001."}
{"id":"CHEMBL2146133","canonicalSmiles":"COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[Mg+2]","inchiKey":"KWORUUGOSLYAGD-YPPDDXJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESOMEPRAZOLE MAGNESIUM","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201320","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Esomeprazole magnesium","Nexium","Nexium 24hr"],"synonyms":["Esomeprazole magnesium","Esomeprazole magnesium hydrate","Esomeprazole magnesium trihydrate","H199/18 MAGNESIUM TRIHYDRATE"],"crossReferences":{"DailyMed":["esomeprazole%20magnesium"],"chEBI":["50309"]},"count":12,"approvedIndications":["EFO_0003948","EFO_0009454","EFO_0000685","EFO_0002506","EFO_0003898","EFO_0004607","EFO_0007549","HP_0100633"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0000280","EFO_0000685","EFO_0003898","EFO_0004607","EFO_0007549","EFO_0008533","EFO_0003948","EFO_0009454","EFO_0002506","MONDO_0004247","EFO_1000961","EFO_0001360","EFO_0000342","HP_0100633"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 8 approved and 4 investigational indications."}
{"id":"CHEMBL2178100","canonicalSmiles":"CN1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)[C@@]1(CO)c1ccccc1","inchiKey":"VAJGULUVTFDTAS-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2178100","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12461"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL219046","canonicalSmiles":"O=C(O)c1c(O)c(Cc2ccc(Cl)cc2)nc2c3c(ccc12)CCCC3","inchiKey":"DIEPFYNZGUUVHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSI-697","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Psi-697"],"crossReferences":{"drugbank":["DB12211"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2221250","canonicalSmiles":"C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H](C2CCNC(=N)N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC1=O.N=C1NCCC([C@@H]2NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC2=O)N1","inchiKey":"VCOPTHOUUNAYKQ-DAOVIKHBSA-N","drugType":"Protein","blackBoxWarning":true,"name":"CAPREOMYCIN","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capastat"],"synonyms":["Capreomycin"],"crossReferences":{"DailyMed":["capreomycin%20sulfate"],"DrugCentral":["3063"]},"childChemblIds":["CHEMBL2218913"],"count":2,"approvedIndications":["Orphanet_3389"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for tuberculosis and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2234294","canonicalSmiles":"O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc([19F])cc1","inchiKey":"LNEPOXFFQSENCJ-YXZYFPPPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[19F]-HALOPERIDOL","maximumClinicalTrialPhase":0,"parentId":"CHEMBL54","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL223873","canonicalSmiles":"Cc1cccc(C)c1Nc1ncc(-c2ccccc2)n2cncc12","inchiKey":"KKYYLKPGILUPOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL223873","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08056"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2263632","canonicalSmiles":"COc1cccc(-c2cc(F)c(Nc3ncccc3C(=O)O)c(F)c2)c1","inchiKey":"OMPATGZMNFWVOH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASLAN-003","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASLAN-003","ASLAN003","Aslan-003","Aslan003"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2303614","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](COC[C@@H]2O[C@H](C(=O)O)[C@@H](CO)[C@H](O)[C@H]2O)[C@@H](CS(=O)(=O)O)[C@@H](CO)O[C@H]1CO","inchiKey":"OAEOAAHCJGWJIC-CEVJMMQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHONDROITIN SULFATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chondroitin Sulfate","Chondroitin sulfate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2311089","canonicalSmiles":"Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.O.O.c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1","inchiKey":"USMXIXZBRZZOQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2311089","maximumClinicalTrialPhase":0,"parentId":"CHEMBL18442","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23261","canonicalSmiles":"COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1","inchiKey":"FEJVSJIALLTFRP-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARUSENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darusentan","HMR-4005","LU-135252","Lu-135252"],"crossReferences":{"PubChem":["170466416"],"Wikipedia":["Darusentan"],"drugbank":["DB04883"]},"count":1,"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL237786","canonicalSmiles":"COc1ccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)cn1","inchiKey":"IFKWHPAWYJARQJ-DYVFJYSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL237786","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08445"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2387742","canonicalSmiles":"C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCC)cc1O","inchiKey":"REOZWEGFPHTFEI-JKSUJKDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANNABIDIVARIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CBD-V","CBDV","Cannabidivarin","GWP42006"],"crossReferences":{"drugbank":["DB14050"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2419346","canonicalSmiles":"CN(C)c1cc2c(cc1Sc1nc3c(N)nccc3n1CCNCC(C)(C)C)OCO2","inchiKey":"RVJIQAYFTOPTKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CUDC-305","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cudc-305","DEBIO-0932"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL258918","canonicalSmiles":"C[C@H]1CC(=O)C[C@@H]2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]12C","inchiKey":"UXYRZJKIQKRJCF-TZPFWLJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESTEROLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pro-viron"],"synonyms":["Mesterolone","SH 723"],"crossReferences":{"Wikipedia":["Mesterolone"],"drugbank":["DB13587"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL25894","canonicalSmiles":"COc1cc(CCC(C)=O)ccc1O","inchiKey":"OJYLAHXKWMRDGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINGERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vanillylacetone","Zingerone"],"crossReferences":{"PubChem":["144212810"],"Wikipedia":["Zingerone"],"drugbank":["DB15589"],"chEBI":["68657"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL274064","canonicalSmiles":"Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1","inchiKey":"VSPFURGQAYMVAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-220025","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-220025"],"crossReferences":{"PubChem":["103905253","124349771","124349772","29217658"],"drugbank":["DB04338"],"chEBI":["82713"]},"childChemblIds":["CHEMBL1909407"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282837","canonicalSmiles":"O=C(Cn1c(Cl)cnc(NCC(F)(F)c2cccc[n+]2[O-])c1=O)NCc1ccccc1F","inchiKey":"ZIGSBBKEPNQXRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL282837","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07550"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303950","canonicalSmiles":"O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccc([N+](=O)[O-])c3cccc1c23","inchiKey":"FLWABCQDXUKNQY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL303950","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08204"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039507","canonicalSmiles":"CCOc1ccc(Cc2cc([C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1","inchiKey":"QKDRXGFQVGOQKS-CRSSMBPESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOTAGLIFLOZIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["LP-802034","LX-4211","LX4211","Sotagliflozin"],"crossReferences":{"drugbank":["DB12713"]},"count":6,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000140675","ENSG00000100170"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003144","EFO_0001359","EFO_0001421","EFO_0001360","EFO_0000400"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for diabetes mellitus and has 5 investigational indications."}
{"id":"CHEMBL3039550","drugType":"Gene","blackBoxWarning":false,"name":"RILIMOGENE GALVACIREPVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Prostvac[tm]"],"synonyms":["Prostvac-V","Rilimogene galvacirepvec","Rilimogene gamvacirepvec"],"count":2,"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3039582","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(N)=O)C(C)C","inchiKey":"OWMZNFCDEHGFEP-NFBCVYDUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SECRETIN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Secretin-ferring","Secretin-kabi"],"synonyms":["Secretin"],"count":6,"linkedTargets":{"rows":["ENSG00000080293"],"count":1},"linkedDiseases":{"rows":["EFO_0000278","EFO_0003758","EFO_0000342","EFO_0001073","EFO_0000692","EFO_0008533"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 6 investigational indications."}
{"id":"CHEMBL3137308","canonicalSmiles":"NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2CC3C[C@@H]1C[C@](O)(C3)C2","inchiKey":"DREIJXJRTLTGJC-ZLBJMMTISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEFICITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-015K","ASP015K","Asp-015k","JNJ-54781532","Peficitinib"],"childChemblIds":["CHEMBL3137329"],"count":5,"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434","ENSG00000105639","ENSG00000105397"],"count":4},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000685","EFO_0000729","EFO_0001421","EFO_0000676"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3137687","canonicalSmiles":"C1CNCCN1.CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O","inchiKey":"HWGAOXKGTHUMFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3137687","maximumClinicalTrialPhase":0,"parentId":"CHEMBL101","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3185133","canonicalSmiles":"C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"ATXHVCQZZJYMCF-XUDSTZEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185133","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205271"],"drugbank":["DB01431"],"chEBI":["31189"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188993","canonicalSmiles":"O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1","inchiKey":"ZTHJULTYCAQOIJ-WXXKFALUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUETIAPINE FUMARATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL716","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Quetiapine fumarate","Seroquel","Seroquel xr"],"synonyms":["FK-947E","FK947E","ICI 204,636","ICI-204636","Quetiapine fumarate","Quetiapine hemifumarate","ZD-5077","ZD5077","ZM 204,636","ZM-204636"],"crossReferences":{"DailyMed":["quetiapine%20fumarate"],"PubChem":["144212683"],"chEBI":["8708"]},"count":17,"approvedIndications":["EFO_0000289","MONDO_0002009","EFO_0003761","EFO_0000692"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0002009","HP_0012076","HP_0000726","EFO_0009963","EFO_0005407","EFO_0001358","EFO_1001917","EFO_0003829","HP_0000713","MONDO_0002046","EFO_0003885","EFO_1001892","EFO_0000289","MONDO_0002050","Orphanet_79292","EFO_0004257","EFO_0003761","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0005411"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 4 approved and 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL321248","canonicalSmiles":"Cn1cnc2nc(O)nc(O)c21","inchiKey":"PFWLFWPASULGAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-METHYLXANTHINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-methylxanthine","NSC-7861"],"crossReferences":{"chEBI":["48991"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL32838","canonicalSmiles":"CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CO2","inchiKey":"NGGMYCMLYOUNGM-CSDLUJIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUMAGILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fumidil"],"synonyms":["Fumagillin"],"crossReferences":{"PubChem":["144205619","144212727","26757080"],"drugbank":["DB02640"],"chEBI":["48635"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3286797","canonicalSmiles":"COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1","inchiKey":"LWJGMYMNSNVCEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04418948","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04418948"],"crossReferences":{"drugbank":["DB12024"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301588","drugType":"Antibody","blackBoxWarning":false,"name":"TAREXTUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OMP-59R5","Tarextumab"],"count":3,"linkedTargets":{"rows":["ENSG00000074181","ENSG00000134250"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0000702"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3526474","canonicalSmiles":"COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCC[14C]4=O)cc2)CC3)cc1","inchiKey":"QNZCBYKSOIHPEH-HWILPRLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526474","maximumClinicalTrialPhase":0,"parentId":"CHEMBL231779","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL353972","canonicalSmiles":"CCC1(c2cnc[nH]2)Cc2ccccc2C1","inchiKey":"HSWPZIDYAHLZDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATIPAMEZOLE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Antisedan"],"synonyms":["Atipamezole","MPV-1248"],"crossReferences":{"PubChem":["144206556","170466187"],"Wikipedia":["Atipamezole"],"drugbank":["DB11481"]},"childChemblIds":["CHEMBL2361649"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544923","drugType":"Antibody","blackBoxWarning":false,"name":"LABETUZUMAB GOVITECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMMU-130","Labetuzumab govitecan"],"count":2,"linkedTargets":{"rows":["ENSG00000105388"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_1000657","MONDO_0021063"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545034","drugType":"Small molecule","blackBoxWarning":false,"name":"ONO-2333MS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ono-2333ms"],"count":1,"linkedTargets":{"rows":["ENSG00000120088"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545040","canonicalSmiles":"CC(C)(C)OC(=O)NCCN1CC2CN(C[C@H](O)COc3ccc(C#N)cc3)CC(C1)O2","inchiKey":"JRHUUZPSMQIWBQ-PELRDEGISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD7009","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd7009"],"count":1,"linkedTargets":{"rows":["ENSG00000183873","ENSG00000055118"],"count":2},"linkedDiseases":{"rows":["EFO_0000275"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545058","canonicalSmiles":"N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-].O.[Na+]","inchiKey":"ANMYAHDLKVNJJO-CURYUGHLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROTHYROXINE SODIUM","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL559","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Choloxin"],"synonyms":["D-thyroxine sodium salt","Dextrothyroxine sodium"],"count":2,"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_1001375","EFO_0000612"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 2 investigational indications."}
{"id":"CHEMBL3545162","drugType":"Small molecule","blackBoxWarning":false,"name":"PBF-680","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pbf-680"],"count":1,"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545228","drugType":"Small molecule","blackBoxWarning":false,"name":"JTS-653","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jts-653"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545244","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLITINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALL-3","Ast-1306"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["MONDO_0008903"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545382","drugType":"Small molecule","blackBoxWarning":false,"name":"R-348","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-348"],"count":1,"linkedTargets":{"rows":["ENSG00000165025","ENSG00000105639"],"count":2},"linkedDiseases":{"rows":["MONDO_0013730","EFO_1000906"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545432","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(=O)O)(CC(=O)O)O1","inchiKey":"MBOMYENWWXQSNW-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IXAZOMIB CITRATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ninlaro"],"synonyms":["Ixazomib citrate","MLN-9708","MLN9708"],"crossReferences":{"DailyMed":["ixazomib%20citrate"]},"count":15,"approvedIndications":["EFO_0000616","EFO_0001378","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000100804"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","MONDO_0013730","EFO_0000616","MONDO_0000873","EFO_0000558","EFO_0000220","EFO_1000314","MONDO_0007254","EFO_0000222","EFO_1001469","EFO_0000311","EFO_0006738","EFO_0006475","EFO_0000574","EFO_0006544","EFO_0001378","MONDO_0020743","EFO_0000519"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 12 investigational indications."}
{"id":"CHEMBL356388","canonicalSmiles":"CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C","inchiKey":"OPQRBXUBWHDHPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETAZOLATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EHT-0202","Etazolate","SQ-20009"],"crossReferences":{"PubChem":["11111137","11113501","124880016","90341463"],"Wikipedia":["Etazolate"]},"childChemblIds":["CHEMBL1256671"],"count":1,"linkedTargets":{"rows":["ENSG00000166206"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL356512","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC=[N+]3CCCCCC3)C(=O)N2[C@H]1C(=O)[O-]","inchiKey":"BWWVAEOLVKTZFQ-NTZNESFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL356512","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01163"],"chEBI":["51208"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL357057","canonicalSmiles":"CNC(=O)c1cccc(CN2[C@H](COc3ccccc3)[C@H](O)[C@@H](O)[C@@H](COc3ccccc3)N(Cc3ccccc3)S2(=O)=O)c1","inchiKey":"CGBDAHCDSVOMCF-FYZVQMPESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL357057","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03076"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL36","canonicalSmiles":"CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1","inchiKey":"WKSAUQYGYAYLPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIMETHAMINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloridin","Daraprim","Malacide"],"synonyms":["GNF-PF-5586","NSC-3061","Pyrimethamine","RP-4753","TCMDC-123831","TCMDC-125860","WR-2978"],"crossReferences":{"DailyMed":["pyrimethamine"],"PubChem":["104171273","11112140","124881960","124881963","124881964","144203883","144209032","144210449","162163291","170464930","17389746","174006175","26747011","26747012","26751532","50100376","50104113","56422411","69611","855854"],"Wikipedia":["Pyrimethamine"],"drugbank":["DB00205"],"chEBI":["8673"]},"count":18,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for malaria and has 17 investigational indications."}
{"id":"CHEMBL3601398","canonicalSmiles":"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2","inchiKey":"CLRSLRWKONPSRQ-IIPSPAQQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CGM-097","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGM 097","CGM-097","CGM097","Cgm-097","Cgm097","NVP-CGM-097"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL360356","canonicalSmiles":"NS(=O)(=O)c1nnc(-c2ccccc2Cl)s1","inchiKey":"PZVGOWIIHCUHAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360356","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07632"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833315","canonicalSmiles":"O=P([O-])([O-])[O-].[Al+3]","inchiKey":"ILRRQNADMUWWFW-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM PHOSPHATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Phosphaljel"],"synonyms":["Aluminium phosphate","Aluminium phosphate gel","Aluminum phosphate"],"crossReferences":{"DrugCentral":["4439"],"drugbank":["DB14517"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3833338","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"CPCMMVSHXFLUOU-HHVGSZDJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTODUOCIN","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3833407","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Combistrep","Distrycin"],"synonyms":["Dihydrostreptomycin-streptomycin","Streptoduocin"],"crossReferences":{"DrugCentral":["4722"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833401","canonicalSmiles":"Cl[Al](Cl)Cl","inchiKey":"VSCWAEJMTAWNJL-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aluminium chloride","Aluminium chloride hexahydrate","Aluminum chloride","Aluminum chloride hexahydrate","NSC-143015","NSC-143016"],"crossReferences":{"drugbank":["DB11081"]},"childChemblIds":["CHEMBL3833314"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL383921","canonicalSmiles":"CCOc1ccccc1O[C@H](c1ccccc1)[C@H]1CNCCO1","inchiKey":"CBQGYUDMJHNJBX-RTBURBONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383921","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00234"]},"childChemblIds":["CHEMBL2105282","CHEMBL1556230"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL384304","canonicalSmiles":"COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N","inchiKey":"JRNJNYBQQYBCLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-547","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R 547","R-547","RG-547","RO4584820","Rg-547","Ro 4584820"],"crossReferences":{"drugbank":["DB08094"]},"count":1,"linkedTargets":{"rows":["ENSG00000123374","ENSG00000135446","ENSG00000170312"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL388931","canonicalSmiles":"CSc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"ZDRFDHHANOYUTE-IOSLPCCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL388931","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02896"],"chEBI":["44081"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3905910","canonicalSmiles":"CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO","inchiKey":"MRPGRAKIAJJGMM-OCCSQVGLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3905910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15157"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL393949","canonicalSmiles":"N[C@H](CCc1ccccc1)P(=O)(O)C[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"QELOIXSGJMIHBZ-MSOLQXFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL393949","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07448"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL394875","canonicalSmiles":"CSC[C@H](N)C(=O)O","inchiKey":"IDIDJDIHTAOVLG-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL394875","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02216"],"chEBI":["45658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL397666","canonicalSmiles":"Cc1cc(-n2ccnc2)cc2nc(-c3c(NCc4ccccn4)cc[nH]c3=O)[nH]c12","inchiKey":"GLTRPHMPCVLOJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL397666","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07474"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL398615","canonicalSmiles":"CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(N)=O)CC1)c1ccccc1S2","inchiKey":"BQDBKDMTIJBJLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOPIMAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EXP 999","Metopimazine"],"crossReferences":{"Wikipedia":["Metopimazine"],"drugbank":["DB13591"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989673","canonicalSmiles":"CS(=O)(=O)O.C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1.O.O.O","inchiKey":"LUILKELNVBKKTG-ZOZJKLBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAXOPRODIL MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL17350","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-101,606-27","Traxoprodil mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989703","canonicalSmiles":"O.O=C(O)[C@@H]1C[C@H]2C[C@@H](CCc3nn[nH]n3)CC[C@H]2CN1","inchiKey":"LNDYQNTTYXLTNH-RTBBDAMFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEZAMPANEL","maximumClinicalTrialPhase":2,"parentId":"CHEMBL14935","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY293558","NGX424","Tezampanel"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989901","canonicalSmiles":"CC(CCCCCCCCCCCCc1ccc([123I])cc1)CC(=O)O","inchiKey":"NPCIWINHUDIWAV-NSYCNWAXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOFILTIC ACID I 123","maximumClinicalTrialPhase":2,"parentId":"CHEMBL336360","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zemiva"],"synonyms":["BMIP-P I-123","BMIPP","BMIPP I-123","Iodofiltic acid (123i)","Iodofiltic acid i 123"],"crossReferences":{"drugbank":["DB05683"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989915","canonicalSmiles":"CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(C(=O)O)CC1","inchiKey":"FWMNVWWHGCHHJJ-SKKKGAJSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DIFELIKEFALIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-PIPERIDINECARBOXYLIC ACID, N1-(D-PHENYLALANYL-D-PHENYLALANYL-D-LEUCYL-D-LYSYL)-4-AMINO-","CR-845","CR845","Difelikefalin","Difelikefalin acetate","FE-202845","FE202845","MR-13A9","MR13A9"],"crossReferences":{"drugbank":["DB11938"]},"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989919","canonicalSmiles":"Cc1ccccc1-c1cc(N2CC[N+](C)(COP(=O)(O)O)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.Cl.[Cl-]","inchiKey":"LBTQUZNIWCWBNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSNETUPITANT CHLORIDE HYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3989917","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["08-PNET","Fosnetupitant chloride","Fosnetupitant chloride hydrochloride"],"crossReferences":{"DailyMed":["fosnetupitant%20chloride%20hydrochloride"]},"count":2,"approvedIndications":["EFO_0006911","HP_0002013"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","HP_0002013"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for chemotherapy-induced nausea and vomiting and vomiting."}
{"id":"CHEMBL3989973","canonicalSmiles":"Cl.FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1","inchiKey":"CJLUYLRKLUYCEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PEXIDARTINIB HYDROCHLORIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3813873","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Turalio"],"synonyms":["FP-113","PLX3397 HCl","Pexidartinib hydrochloride"],"crossReferences":{"DailyMed":["pexidartinib%20hydrochloride"]},"count":1,"approvedIndications":["EFO_1000562"],"linkedTargets":{"rows":["ENSG00000157404","ENSG00000182578","ENSG00000122025"],"count":3},"linkedDiseases":{"rows":["EFO_1000562"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for tenosynovial giant cell tumor. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3990011","drugType":"Antibody","blackBoxWarning":false,"name":"ROVALPITUZUMAB TESIRINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rovalpituzumab tesirine","SC-002","SC0002"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3990456","canonicalSmiles":"Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c(=O)[nH]ncc2c34)cn1","inchiKey":"NDEXUOWTGYUVGA-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3990456","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12611"]},"childChemblIds":["CHEMBL4299711"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL403350","canonicalSmiles":"Clc1cccc(-c2cc(NCc3ccncc3)n3nccc3n2)c1Cl","inchiKey":"CVYWYUAQFJMLEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL403350","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4073292","canonicalSmiles":"CN1CCN(c2cccc3c2CCN(C(=O)/C=C/c2c(-n4cnnn4)ccc(Cl)c2F)[C@@H]3C(=O)Nc2ccc(C(=O)O)cc2)C(=O)C1","inchiKey":"WYFCZWSWFGJODV-MIANJLSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-962212","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-962212","Bms-962212"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4085457","canonicalSmiles":"C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C","inchiKey":"CBRJPFGIXUFMTM-WDEREUQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06651600","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06651600","Pf-06651600","Ritlecitinib"],"crossReferences":{"drugbank":["DB14924"]},"count":7,"linkedTargets":{"rows":["ENSG00000135605","ENSG00000074966","ENSG00000105639","ENSG00000010671","ENSG00000113263","ENSG00000102010"],"count":6},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000685","EFO_0000729","EFO_0004192","EFO_0001421","EFO_0004208","EFO_0000384"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL409153","canonicalSmiles":"C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1cc(F)ccc1F","inchiKey":"DDFOUSQFMYRUQK-RCDICMHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISAVUCONAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cresemba"],"synonyms":["BAL-4815","Isavuconazole"],"crossReferences":{"Wikipedia":["Isavuconazole"],"drugbank":["DB11633"],"chEBI":["85979"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4092757","canonicalSmiles":"O=S(=O)(O)c1ccccc1.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1","inchiKey":"GNUBRTZJEGSLCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4092757","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL41","canonicalSmiles":"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1","inchiKey":"RTHCYVBBDHJXIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUOXETINE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fluoxetine","NSC-283480","Prozac","Sarafem","Symbyax"],"crossReferences":{"DailyMed":["fluoxetine%20hydrochloride"],"PubChem":["104171153","144203695","170465374","26751973","26755310","50104648","90341619"],"Wikipedia":["Fluoxetine"],"drugbank":["DB00472"],"chEBI":["86990"]},"childChemblIds":["CHEMBL1201082"],"count":28,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0005687","EFO_0004262","EFO_0002610","MONDO_0002009","HP_0000726","EFO_0005669","EFO_0003768","EFO_1001917","HP_0011868","EFO_0007191","EFO_0003948","HP_0100543","EFO_0000289","MONDO_0002050","EFO_0000474","MONDO_0021698","EFO_0000712","EFO_0003761","EFO_0009854","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0008522","EFO_0004215","HP_0002140","HP_0012076","EFO_0000677","EFO_0003758","EFO_0005407","EFO_0001358","EFO_0001073","EFO_1001050","EFO_0008623","MONDO_0100096","EFO_0001359"],"count":36},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for unipolar depression and has 27 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL41286","canonicalSmiles":"CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O","inchiKey":"TYNLGDBUJLVSMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIACEREIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fisiodar"],"synonyms":["AC-201","Artrodar","Diacerein","M-01AX21","M01AX21","Rhein diacetate","SF-277"],"crossReferences":{"PubChem":["104171387","144204407","170466475","26746957","855680"],"Wikipedia":["Diacerein"],"drugbank":["DB11994"]},"count":11,"approvedIndications":["EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 10 investigational indications."}
{"id":"CHEMBL421615","canonicalSmiles":"O=C(O)c1cc(O)c2c(c1)Cc1cccc(O)c1C2=O","inchiKey":"OZFQHULMMDWMIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL421615","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["508365"],"drugbank":["DB13175"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL422648","canonicalSmiles":"Cc1oc(=O)oc1CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)c2n3C(C)S2)CC1","inchiKey":"PWNMXPDKBYZCOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRULIFLOXACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NM-441","NM441","Prulifloxacin"],"crossReferences":{"PubChem":["144205788","170465849","26758037"],"drugbank":["DB11892"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL42442","canonicalSmiles":"COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1","inchiKey":"BEZZFPOZAYTVHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXFENDAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxfendazole","RS-8858"],"crossReferences":{"PubChem":["144206994","144212700","170466223","174006235","26749019"],"Wikipedia":["Oxfendazole"],"drugbank":["DB11446"],"chEBI":["35812"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297217","canonicalSmiles":"CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21.O=S(=O)(O)c1ccccc1","inchiKey":"UQGMFOYDYUZADE-FERBBOLQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOLIBRESIB BESYLATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1232461","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-525762C","GSK525762C","Molibresib besylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297224","canonicalSmiles":"CN(C)CC1CCOC1(c1ccccc1)c1ccccc1","inchiKey":"BOTHKNZTGGXFEQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BLARCAMESINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Anavex"],"synonyms":["Anavex 2-73","Blarcamesine"],"crossReferences":{"drugbank":["DB05592"]},"childChemblIds":["CHEMBL4594269"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297260","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H](C(=O)N(C)[C@H](C(N)=O)[C@@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cn(C)c3ccccc23)NC(=O)[C@H](C(C)C)NC1=O","inchiKey":"MUSGYEMSJUFFHT-UWABRSFTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"AMY-101","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amy-101"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297289","canonicalSmiles":"CN1CCN(C(=O)[C@H](CCCN[C@@H]2C[C@H]2c2ccc(F)cc2)NC(=O)c2ccc(-n3ccnn3)cc2)CC1","inchiKey":"KQKBMHGOHXOHTD-KKUQBAQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMG-7289","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bomedemstat","Img-7289"],"crossReferences":{"drugbank":["DB15126"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297340","drugType":"Protein","blackBoxWarning":false,"name":"GALLIUM OXODOTREOTIDE GA-68","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL262135","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gallium dotatoc ga 68","Netspot"],"synonyms":["68ga-dotatate","Gallium (68ga) dotatate","Gallium dotatate ga-68","Gallium dotatoc ga-68","Gallium oxodotreotide ga-68"],"crossReferences":{"DailyMed":["gallium%20dotatate%20ga-68"]},"count":3,"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 3 investigational indications."}
{"id":"CHEMBL4297402","canonicalSmiles":"Cc1nnnn1N=Cc1ccc(O)c(C(c2ccc(O)cc2)c2cc(C=Nn3nnnc3C)ccc2O)c1","inchiKey":"BLUJRJMLDHEMRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VP-14637","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mdt-637","Vp-14637"],"crossReferences":{"drugbank":["DB12195"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297451","canonicalSmiles":"CC[C@@H](C)Nc1cc(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3c2ccc(C(=O)C3CC3)cn2)c(C)cc1C(N)=O","inchiKey":"LHGWWAFKVCIILM-HLRQEUIKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-888","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xl-888","Xl888"],"crossReferences":{"drugbank":["DB12981"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297542","canonicalSmiles":"CC(C)Oc1ncc(-c2nc(-c3cccc4c3ccn4CCCC(=O)O)no2)cc1Cl","inchiKey":"NFIGDBFIDKDNIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2018682","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK2018682","Gsk-2018682","Gsk2018682"],"crossReferences":{"drugbank":["DB11987"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297571","drugType":"Unknown","blackBoxWarning":false,"name":"AK-105","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-105","AK105","Ak-105","Ak105"],"count":6,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297590","canonicalSmiles":"COc1ccc(-n2nccn2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1","inchiKey":"NBGABHGMJVIVBW-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEMOREXANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-541468","Act-541468","Daridorexant","Nemorexant"],"crossReferences":{"drugbank":["DB15031"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297744","drugType":"Unknown","blackBoxWarning":false,"name":"ELX-02","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ELX-02","Elx-02","Exaluren","NB-124"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297829","drugType":"Antibody","blackBoxWarning":false,"name":"SINTILIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-PD-1 MONOCLONAL ANTIBODY IBI308","IBI-308","IBI308","Ibi308","Sintilimab"],"count":25,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 25 investigational indications."}
{"id":"CHEMBL4297853","drugType":"Unknown","blackBoxWarning":false,"name":"MIP-1095 I-131","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["131I-MIP-1095","131i-mip-1095","IODINE I 131 MIP-1095","IODINE I-131 MIP-1095","MIP-1095 I-131","Mip-1095 i-131"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297876","drugType":"Antibody","blackBoxWarning":false,"name":"ZALIFRELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGEN1884","Agen1884","Zalifrelimab"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297955","drugType":"Unknown","blackBoxWarning":false,"name":"FOLLITROPIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rekovelle"],"synonyms":["Fe 999049","Follitropin","Follitropin alpha","Follitropin delta","Follitropin epsilon","Follitropin gamma","Gonal f"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298090","drugType":"Protein","blackBoxWarning":false,"name":"SIMLUKAFUSP ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FAP-IL-2V","FAP-IL2V FP RO6874281","FAP-IL2v","RG-7461","RG7461","RO-6874281","RO6874281","Ro-6874281","Ro6874281","Simlukafusp alfa"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298150","canonicalSmiles":"CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1.CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1.O=C(O)/C=C/C(=O)O","inchiKey":"JNLIKIBISICTMS-PEJBKAKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIPONIMOD FUMARATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2336071","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mayzent"],"synonyms":["NVP-BAF312-AEA","Siponimod fumarate","Siponimod fumaric acid"],"crossReferences":{"DailyMed":["siponimod%20fumaric%20acid"]},"count":3,"approvedIndications":["EFO_0003885","EFO_0003840","EFO_0003929"],"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003840","EFO_0003929"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved indications."}
{"id":"CHEMBL4298190","drugType":"Cell","blackBoxWarning":false,"name":"OMIDUBICEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nicord"],"synonyms":["Cultured fraction, CF","Omidubicel"],"count":1,"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL435381","canonicalSmiles":"COc1ccc(-c2c(Cl)ncn2-c2ccc(S(N)(=O)=O)cc2)cc1F","inchiKey":"KYXDNECMRLFQMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIMICOXIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cimicoxib"],"crossReferences":{"drugbank":["DB05095"],"chEBI":["76127"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL440510","canonicalSmiles":"CC(C)OC(=O)c1cc(NC(=S)OC(C)C)ccc1Cl","inchiKey":"AXTNFJKQZPETJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL440510","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["494463"],"drugbank":["DB08681"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4437054","canonicalSmiles":"CS(=O)(=O)CCCn1c(Cn2c(=O)n(CC(F)(F)F)c3ccncc32)cc2cc(Cl)ccc21","inchiKey":"GTQTUABHRCWVLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILEMATOVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-53718678","Rilematovir"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL450895","canonicalSmiles":"C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2","inchiKey":"VQOXZBDYSJBXMA-NQTDYLQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NYSTATIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Barstatin 100","Candex","Infestat","Korostatin","Multilind","Myco 20","Mycostatin","Mykinac","Nilstat","Nysert","Nyspes","Nystaform","Nystan triple pack","Nystatin","Nystavescent","Nystex","Nystop","Tinaderm m"],"synonyms":["NSC-150817","Nystatin"],"crossReferences":{"DailyMed":["nystatin"]},"childChemblIds":["CHEMBL3109319"],"count":17,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 17 investigational indications."}
{"id":"CHEMBL451","canonicalSmiles":"CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1","inchiKey":"ANTSCNMPPGJYLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORDIAZEPOXIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clopoxide","Librelease","Libritabs","Librium","Sarlib","Trakipeal","Zeisin"],"synonyms":["A-Poxide","Chlordiazachel","Chlordiazepoxide","Chlordiazepoxide civ","Clopoxide","Librium","Lygen"],"crossReferences":{"DailyMed":["chlordiazepoxide","chlordiazepoxide%20hydrochloride"],"PubChem":["144205120","144205121","49648393"],"Wikipedia":["Chlordiazepoxide"],"drugbank":["DB00475"],"chEBI":["3611"]},"childChemblIds":["CHEMBL1200703"],"count":4,"approvedIndications":["EFO_0005230"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000113327","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004777","MONDO_0002009","EFO_0005230","EFO_0003829"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for anxiety and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL452076","canonicalSmiles":"COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1","inchiKey":"KJEBULYHNRNJTE-DHZHZOJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILNIDIPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilnidipine","FRC-8653"],"crossReferences":{"PubChem":["144205554","170465867","26755677","50111041","90341030"],"drugbank":["DB09232"],"chEBI":["31399"]},"count":3,"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0000319","EFO_1001496","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL455136","canonicalSmiles":"CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1","inchiKey":"DKMACHNQISHMDN-RPLLCQBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMOREXANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-078573","Almorexant"],"crossReferences":{"Wikipedia":["Almorexant"],"drugbank":["DB06673"]},"childChemblIds":["CHEMBL3542330"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL45627","canonicalSmiles":"C/C=C/C/C=C/CCC(=O)[C@H]1O[C@H]1C(N)=O","inchiKey":"GVEZIHKRYBHEFX-NQQPLRFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CERULENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cerulenin"],"crossReferences":{"PubChem":["131404641","131404693","26756878"],"Wikipedia":["Cerulenin"],"drugbank":["DB01034"],"chEBI":["171741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL458537","canonicalSmiles":"Cl.Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O","inchiKey":"WIXFPWNBCBVIFA-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL458537","maximumClinicalTrialPhase":0,"parentId":"CHEMBL376359","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594358","drugType":"Unknown","blackBoxWarning":false,"name":"KO-539","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KO-539","KO539","Ko-539"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594455","drugType":"Unknown","blackBoxWarning":false,"name":"AGS-16C3F","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADC AGS-16C3F","AGS-16C3F","Ags-16c3f"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594577","drugType":"Unknown","blackBoxWarning":false,"name":"MGD-009","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MGD-009","MGD009","Mgd-009","Mgd009"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL476413","canonicalSmiles":"[11CH3]Oc1ccc(-c2c(C#N)c(C(=O)NN3CCCCC3)nn2-c2ccc(Cl)cc2Cl)cc1","inchiKey":"MCNQUWLLXZZZAC-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JHU-75528 C-11","maximumClinicalTrialPhase":0,"parentId":"CHEMBL514215","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["11c-omar","Jhu-75528 c-11","[11C]NIDA41020"],"crossReferences":{"drugbank":["DB14902"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL500","canonicalSmiles":"CC(C)NCC(O)COc1cccc2[nH]ccc12","inchiKey":"JZQKKSLKJUAGIC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINDOLOL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betadren","Pindolol","Visken"],"synonyms":["LB-46","Pindolol","Prinodolol"],"crossReferences":{"DailyMed":["pindolol"],"PubChem":["104171209","144203772","170464892","26747148","26747149","26752014","50104680","50104681","85231175","855790","90341348"],"Wikipedia":["Pindolol"],"drugbank":["DB00960"],"chEBI":["8214"]},"count":3,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","EFO_0003761","EFO_0000319"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL511115","canonicalSmiles":"COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1","inchiKey":"CFBUZOUXXHZCFB-OYOVHJISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILOMILAST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilomilast","SB 207499","SB-207499"],"crossReferences":{"PubChem":["144206070"],"Wikipedia":["Cilomilast"],"drugbank":["DB03849"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL515408","canonicalSmiles":"CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O","inchiKey":"KJFBVJALEQWJBS-XUXIUFHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MARIBAVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1263-W-94","1263W94","Maribavir"],"crossReferences":{"drugbank":["DB06234"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL522302","canonicalSmiles":"COc1ccc(-n2nnnc2C(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1","inchiKey":"XILNRORTJVDYRH-HKUYNNGSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOFOPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GR-205171","GR205171","Gr-205171","Vofopitant"],"crossReferences":{"drugbank":["DB12436"]},"childChemblIds":["CHEMBL557983"],"count":3,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","EFO_0001358","EFO_0004698"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL529","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"MQTOSJVFKKJCRP-BICOPXKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZITHROMYCIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azasite","Azithromycin","Azyter","Clamelle","Sumamed","Sunamed","ZMax","Zithromax"],"synonyms":["Azithromycin","Azithromycin dihydrate","Azithromycin hydrate","CP 62993","CP-62,993","CP-62993","XZ 405","XZ 450","XZ-450"],"crossReferences":{"DailyMed":["azithromycin"],"PubChem":["144204559","144208209","17389173","49648620"],"Wikipedia":["Azithromycin"],"drugbank":["DB00207"],"chEBI":["2955"]},"childChemblIds":["CHEMBL1200502"],"count":69,"approvedIndications":["EFO_0003106","EFO_0000771","HP_0011110","Orphanet_586","EFO_1001888","MONDO_0002258","EFO_0003878"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 7 approved and 62 investigational indications."}
{"id":"CHEMBL539378","canonicalSmiles":"COC(=O)c1cnc2n1CCc1ccccc1C2=C1CCN(CCc2ccc(OCc3ccc4ccccc4n3)cc2)CC1","inchiKey":"TULGGJGJQXESOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANIQUIDAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Laniquidar"],"crossReferences":{"drugbank":["DB12799"]},"childChemblIds":["CHEMBL567377"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL542257","canonicalSmiles":"CCCN[C@H]1CCc2nc(N)sc2C1.Cl","inchiKey":"YLOYRMPMRZXEMW-FJXQXJEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMIPEXOLE DIHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL301265","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mirapex","Mirapex Er","Mirapex Extended Release","Pramipexole Dihydrochloride"],"synonyms":["SND-919CL2Y"],"crossReferences":{"PubChem":["49681827"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL542549","canonicalSmiles":"Cl.O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1","inchiKey":"CWKFWBJJNNPGAM-IPZCTEOASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL542549","maximumClinicalTrialPhase":0,"parentId":"CHEMBL11662","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204244","170466054","49681562"],"chEBI":["31954"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54976","canonicalSmiles":"N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O","inchiKey":"QIVBCDIJIAJPQS-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRYPTOPHAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Germany"],"classes":["Hematological toxicity"],"year":1989},"tradeNames":["Gppe pdr sach","Optimax","Optimax wv","Pacitron"],"synonyms":["L-tryptophan","NSC-13119","Tryptophan","Tryptophan, l-"],"crossReferences":{"PubChem":["11111851","144208444","144210677","26732620","50107108","50107109","90341602"],"Wikipedia":["Tryptophan"],"drugbank":["DB00150"],"chEBI":["16828"]},"count":7,"approvedIndications":["EFO_0003761"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for unipolar depression and has 6 investigational indications. It was withdrawn in United Kingdom and  Germany initially in 1989 due to Hematological toxicity."}
{"id":"CHEMBL55214","canonicalSmiles":"NCCCCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"PUUSSSIBPPTKTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERIDRONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neridronic acid"],"crossReferences":{"drugbank":["DB11620"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL559","canonicalSmiles":"N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O","inchiKey":"XUIIKFGFIJCVMT-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROTHYROXINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thyroxine"],"synonyms":["Choloxin","D-thyroxine","Dextrothyroxine","Liotrix"],"crossReferences":{"PubChem":["11112110"],"Wikipedia":["Dextrothyroxine"],"drugbank":["DB00509"],"chEBI":["30659"]},"childChemblIds":["CHEMBL1200777","CHEMBL3545058"],"count":2,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_1001375","EFO_0000612","EFO_0000319","EFO_0001064"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL561639","canonicalSmiles":"O=C(c1ccc(OC[C@H]2CCCN2)cc1)c1ccc(-c2ccsc2)cc1","inchiKey":"VUWFJUJWAWMRQN-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561639","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07237"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL562318","canonicalSmiles":"Cn1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1","inchiKey":"AZEXWHKOMMASPA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MARDEPODECT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MP-10","Mardepodect","PF-02545920","PF-2545920"],"crossReferences":{"PubChem":["165222673","174006264"],"drugbank":["DB08387"]},"childChemblIds":["CHEMBL1684440"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL591665","canonicalSmiles":"O=C1O[C@H]([C@@H](O)CO)C([O-])=C1O.[Na+]","inchiKey":"PPASLZSBLFJQEF-RXSVEWSESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM ASCORBATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ascorbin","Cevalin","Sodium Ascorbate"],"synonyms":["Ascorbic acid sodium salt","E-301","E301","INS NO.301","INS-301","Sodium ascorbate"],"crossReferences":{"DailyMed":["sodium%20ascorbate"],"PubChem":["144210873"],"Wikipedia":["Sodium_ascorbate"],"drugbank":["DB14482"]},"count":5,"approvedIndications":["EFO_0004272","EFO_0001070","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL602","canonicalSmiles":"NCCS","inchiKey":"UFULAYFCSOUIOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTEAMINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cystagon","Procysbi"],"synonyms":["Cystagon","Cysteamine","L-1573","MEA","Mercaptamine","NSC-647528"],"crossReferences":{"DailyMed":["cysteamine%20bitartrate","cysteamine%20hydrochloride"],"PubChem":["11111480","144206643","90341118"],"Wikipedia":["Cysteamine"],"drugbank":["DB00847"],"chEBI":["17141"]},"childChemblIds":["CHEMBL1256137","CHEMBL2062263","CHEMBL3763421"],"count":5,"approvedIndications":["EFO_0003966"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for eye disease and has 4 investigational indications."}
{"id":"CHEMBL617","canonicalSmiles":"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1","inchiKey":"XIURVHNZVLADCM-IUODEOHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALOTHIN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefalotin","Cephalothin","Seffin"],"crossReferences":{"PubChem":["144205132","170465101","29215241","47193756","90341219"],"TG-GATEs":["141"],"Wikipedia":["Cefalotin"],"drugbank":["DB00456"],"chEBI":["124991"]},"childChemblIds":["CHEMBL1632"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for bacterial disease."}
{"id":"CHEMBL64934","canonicalSmiles":"O=C(O)C(=O)N(c1ccccc1C(=O)O)c1cccc2ccccc12","inchiKey":"WQWCUHJIERBOSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL64934","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03982"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL661","canonicalSmiles":"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2","inchiKey":"VREFGVBLTWBCJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALPRAZOLAM","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alprazolam","Niravam","Xanax","Xanax xr"],"synonyms":["Alprazolam","Alprazolam civ","U 31,889","U-31,889","U-31889"],"crossReferences":{"DailyMed":["alprazolam"],"PubChem":["144205245","26719699","29215419"],"Wikipedia":["Alprazolam"],"drugbank":["DB00404"],"chEBI":["2611"]},"count":12,"approvedIndications":["EFO_0004262","EFO_0006788","EFO_0005230"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000163285","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004262","EFO_0006788","EFO_0003821","HP_0000726","EFO_0001358","EFO_1001917","EFO_1001884","EFO_1001892","EFO_0000474","MONDO_0002050","EFO_0003890","EFO_0001359","EFO_0005230","EFO_0000692"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL66879","canonicalSmiles":"O=C(O)/C=C/c1ccc(O)cc1","inchiKey":"NGSWKAQJJWESNS-ZZXKWVIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COUMARIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P-Coumaric Acid"],"crossReferences":{"PubChem":["47193719"],"Wikipedia":["P-Coumaric_acid"],"drugbank":["DB04066"],"chEBI":["32374"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL67158","canonicalSmiles":"CCCCCCCCCCNC(=O)NC1CCCCC1","inchiKey":"LPXYBLIRYGCMPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL67158","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03677"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL695","canonicalSmiles":"CN1C(=O)OC(C)(C)C1=O","inchiKey":"IRYJRGCIQBGHIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHADIONE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tridione"],"synonyms":["Trimethadione","Troxidone"],"crossReferences":{"PubChem":["11112276","144203959","144207429"],"TG-GATEs":["122"],"Wikipedia":["Trimethadione"],"drugbank":["DB00347"]},"count":1,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000100346","ENSG00000006283","ENSG00000196557"],"count":3},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946 and is indicated for epilepsy."}
{"id":"CHEMBL7064","canonicalSmiles":"O=C1c2ccccc2-c2n[nH]c3cccc1c23","inchiKey":"ACPOUJIDANTYHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL7064","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905675","11111809","11114107","117321","124881463","124881465","124881466","144203818","26752203","26752204","50104867","50104868","85231230","90341633"],"Wikipedia":["1,9-Pyrazoloanthrone"],"drugbank":["DB01782"],"chEBI":["90695"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL75232","canonicalSmiles":"Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1.O=C(O)CCC(=O)O","inchiKey":"LLDWLPRYLVPDTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CGP-79787D","maximumClinicalTrialPhase":0,"parentId":"CHEMBL101253","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP-79787D"],"crossReferences":{"chEBI":["90623"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL834","canonicalSmiles":"NCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"WRUUGTRCQOWXEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMIDRONIC ACID","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CGP-23339AE","Pamidronate","Pamidronic Acid","Pamidronic acid"],"crossReferences":{"DailyMed":["pamidronate%20disodium"],"PubChem":["144205217","170464689","29215372","29217620"],"Wikipedia":["Pamidronic_acid"],"drugbank":["DB00282"]},"childChemblIds":["CHEMBL676","CHEMBL3989401"],"count":5,"approvedIndications":["EFO_0004260"],"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["HP_0000938","EFO_0003898","MONDO_0007254","EFO_0000706","EFO_0001378","HP_0003419","EFO_0004260","Orphanet_666","EFO_0003882","EFO_1001164"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for bone disease and has 4 investigational indications."}
{"id":"CHEMBL855","canonicalSmiles":"Cc1ccc(/C(=C\\CN2CCCC2)c2ccccn2)cc1","inchiKey":"CBEQULMOCCWAQT-WOJGMQOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPROLIDINE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Actahist","Actidil","Actifed","Allerfed","Corphed","Histafed","Myfed","Myidyl","Trilitron","Triphed","Triprolidine"],"crossReferences":{"DailyMed":["triprolidine%20hydrochloride"],"PubChem":["144204470","170464931","26751829","50104523","50104524","50104525","90341007"],"Wikipedia":["Triprolidine"],"drugbank":["DB00427"],"chEBI":["84116"]},"childChemblIds":["CHEMBL1200450","CHEMBL3188034"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and is indicated for allergy."}
{"id":"CHEMBL93836","canonicalSmiles":"CCCC(CCC)C(N)=O","inchiKey":"OMOMUFTZPTXCHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALPROMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valpromide"],"crossReferences":{"PubChem":["144206685"],"Wikipedia":["Valpromide"],"drugbank":["DB04165"],"chEBI":["74562"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL99946","canonicalSmiles":"CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN","inchiKey":"GJJFMKBJSRMPLA-DZGCQCFKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVOMILNACIPRAN","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fetzima"],"synonyms":["F 2695","F-2695","F2695","Levomilnacipran"],"crossReferences":{"DailyMed":["levomilnacipran%20hydrochloride"],"drugbank":["DB08918"]},"childChemblIds":["CHEMBL2105732"],"count":3,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["HP_0002140","MONDO_0002009","EFO_0003761","EFO_0003768"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 investigational indications. This drug has a black box warning from the FDA."}
